Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Free testosterone by direct and calculated measurement versus equilibrium dialysis in a clinical population.
Kacker R, Hornstein A, Morgentaler A. Kacker R, et al. Among authors: morgentaler a. Aging Male. 2013 Dec;16(4):164-8. doi: 10.3109/13685538.2013.835800. Epub 2013 Oct 3. Aging Male. 2013. PMID: 24090209
Is low serum free testosterone a marker for high grade prostate cancer?
Hoffman MA, DeWolf WC, Morgentaler A. Hoffman MA, et al. Among authors: morgentaler a. J Urol. 2000 Mar;163(3):824-7. J Urol. 2000. PMID: 10687985
The value of pituitary magnetic resonance imaging in men with hypogonadism.
Rhoden EL, Estrada C, Levine L, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Sep;170(3):795-8. doi: 10.1097/01.ju.0000082960.84075.54. J Urol. 2003. PMID: 12913700
Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Dec;170(6 Pt 1):2348-51. doi: 10.1097/01.ju.0000091104.71869.8e. J Urol. 2003. PMID: 14634413
Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. N Engl J Med. 2004 Jan 29;350(5):482-92. doi: 10.1056/NEJMra022251. N Engl J Med. 2004. PMID: 14749457 Review. No abstract available.
Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. Int J Impot Res. 2004 Feb;16(1):95-7. doi: 10.1038/sj.ijir.3901154. Int J Impot Res. 2004. PMID: 14963480
A 66-year-old man with sexual dysfunction.
Morgentaler A. Morgentaler A. JAMA. 2004 Jun 23;291(24):2994-3003. doi: 10.1001/jama.291.24.2994. JAMA. 2004. PMID: 15213212 No abstract available.
Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. Int J Impot Res. 2006 Mar-Apr;18(2):201-5. doi: 10.1038/sj.ijir.3901394. Int J Impot Res. 2006. PMID: 16177827
Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
Lazarou S, Morgentaler A. Lazarou S, et al. Among authors: morgentaler a. Curr Urol Rep. 2005 Nov;6(6):476-81. doi: 10.1007/s11934-005-0044-z. Curr Urol Rep. 2005. PMID: 16238923 Review.
Testosterone replacement therapy and prostate risks: where's the beef?
Morgentaler A. Morgentaler A. Can J Urol. 2006 Feb;13 Suppl 1:40-3. Can J Urol. 2006. PMID: 16526980 Review.
185 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback